Genentech | Roche | environmental violation | 2023 | EPA | $158,209 |
Sandoz, Inc. | Sandoz Group | HHS civil monetary penalties | 2015 | HHSOIG | $12,640,000 |
Sandoz, Inc. | Sandoz Group | HHS civil monetary penalties | 2011 | HHSOIG | $230,000 |
Sandoz | Sandoz Group | False Claims Act and related | 2009 | KY-AG | $16,000,000 |
Sandoz | Sandoz Group | False Claims Act and related | 2013 | LA-AG | $13,100,000 |
Sandoz Inc. | Sandoz Group | False Claims Act and related | 2010 | ID-AG | $1,650,000 |
Sandoz, Inc. | Sandoz Group | False Claims Act and related | 2011 | MS-AG | $30,110,618 |
Sandoz Inc. | Sandoz Group | price-fixing or anti-competitive practices | 2020 | DOJ_ANTITRUST | $195,000,000 |
Sandoz Inc. | Sandoz Group | False Claims Act and related | 2021 | DOJ_CIVIL | $185,000,000 |
Sandoz Inc. | Sandoz Group | price-fixing or anti-competitive practices | 2017 | private lawsuit-federal | $1,750,000 |
Sandoz Inc. | Sandoz Group | price-fixing or anti-competitive practices | 2017 | private lawsuit-federal | $3,202,500 |
Sandoz Inc. | Sandoz Group | price-fixing or anti-competitive practices | 2020 | private lawsuit-federal | $85,000,000 |
Sandoz Inc. | Sandoz Group | price-fixing or anti-competitive practices | 2011 | private lawsuit-federal | $150,000,000 |
Genzyme Corporation | Sanofi | drug or medical equipment safety violation | 2015 | FDA | $32,587,439 |
Sanofi-Aventis U.S. Inc. | Sanofi | False Claims Act and related | 2012 | DOJ_CIVIL | $109,000,000 |
Genzyme Corp. | Sanofi | False Claims Act and related | 2013 | DOJ_CIVIL | $22,280,000 |
Hoechst AG | Sanofi | price-fixing or anti-competitive practices | 2003 | DOJ_ANTITRUST | $12,000,000 |
Aventis Pharmaceutical Inc. | Sanofi | False Claims Act and related | 2009 | DOJ_CIVIL | $95,500,000 |
Aventis Pharmaceuticals Inc. | Sanofi | False Claims Act and related | 2007 | DOJ_CIVIL | $190,000,000 |
Sanofi-Pasteur | Sanofi | False Claims Act and related | 2017 | DOJ_CIVIL | $19,868,194 |
Roussel Uclaf S.A. | Sanofi | drug or medical equipment safety violation | 2001 | USAO | $23,193,600 |
Sanofi | Sanofi | Foreign Corrupt Practices Act | 2018 | SEC | $25,200,000 |
Sanofi-Aventis U.S. LLC | Sanofi | employment discrimination | 2010 | private lawsuit-federal | $15,360,000 |
Aventis | Sanofi | False Claims Act and related | 2013 | LA-AG | $7,000,000 |
Aventis Pharmaceutical Inc. | Sanofi | False Claims Act and related | 2009 | MULTI-AG | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $40,000,000 |
Aventis Pharmaceutical L.P. | Sanofi | False Claims Act and related | 2009 | AL-AG | $14,833,333 |
Aventis Pharmaceuticals Inc. | Sanofi | False Claims Act and related | 2007 | MULTI-AG | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $10,645,600 |
Aventis Pharmaceuticals Inc. | Sanofi | False Claims Act and related | 2010 | NJ-AG | $1,300,000 |
Aventis Pharmaceuticals Inc. | Sanofi | price-fixing or anti-competitive practices | 2003 | MULTI-AG | $40,000,000 |
Aventis Pharmaceuticals, Inc. | Sanofi | price-fixing or anti-competitive practices | 2012 | MULTI-AG | $1,650,000 |
Aventis Pharmaceuticals, Inc. and Aventis Behring, LLC | Sanofi | False Claims Act and related | 2012 | KY-AG | $2,290,000 |
Genzyme Corp. | Sanofi | False Claims Act and related | 2013 | MULTI-AG | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $22,280,000 |
Sanofi US Services, Inc. | Sanofi | kickbacks and bribery | 2013 | MULTI-AG | $617,000 |
Sanofi-Aventis | Sanofi | consumer protection violation | 2019 | WV-AG | $1,600,000 |
Sanofi-Aventis U.S. LLC | Sanofi | False Claims Act and related | 2012 | ID-AG | $828,500 |
Aventis Pharmaceuticals | Sanofi | False Claims Act and related | 2019 | IL-AG | $14,708,388 |
Sanofi-Aventis U.S., LLC | Sanofi | False Claims Act and related | 2020 | USAO | $11,850,000 |
SANOFI PASTEUR | Sanofi | environmental violation | 2006 | PA-ENV | $28,620 |
SANOFI PASTEUR | Sanofi | environmental violation | 2007 | PA-ENV | $6,400 |
Aventis Pharmaceuticals Inc. | Sanofi | price-fixing or anti-competitive practices | 2013 | private lawsuit-federal | $800,000 |
Aventis Pharmaceuticals Inc. | Sanofi | price-fixing or anti-competitive practices | 2011 | private lawsuit-federal | $3,500,000 |
Aventis Pharmaceuticals Inc. | Sanofi | price-fixing or anti-competitive practices | 2011 | private lawsuit-federal | $9,615,384 |
Aventis Pharmaceuticals Inc. | Sanofi | price-fixing or anti-competitive practices | 2000 | private lawsuit-federal | $22,000,000 |
Hoechst AG | Sanofi | price-fixing or anti-competitive practices | 2000 | private lawsuit-federal | $37,000,000 |
Hoechst Marion Roussel | Sanofi | price-fixing or anti-competitive practices | 2011 | private lawsuit-federal | $9,615,384 |
Hoechst Marion Roussel | Sanofi | price-fixing or anti-competitive practices | 2003 | private lawsuit-federal | $55,000,000 |
Hoechst Marion Roussel, Inc. | Sanofi | price-fixing or anti-competitive practices | 2016 | private lawsuit-state | $50,000,000 |
Sanofi Pasteur Inc. | Sanofi | price-fixing or anti-competitive practices | 2017 | private lawsuit-federal | $61,500,000 |
SANOFI PASTEUR INC. | Sanofi | workplace safety or health violation | 2014 | OSHA | $7,000 |
IMO SANOFI PASTEUR | Sanofi | hazardous waste violation | 2014 | EPA | $77,643 |
SciClone Pharmaceuticals | SciClone Pharmaceuticals | Foreign Corrupt Practices Act | 2016 | SEC | $12,000,000 |
Galena Biopharma, Inc. | SELLAS Life Sciences Group | accounting fraud or deficiencies | 2017 | SEC | $200,000 |
Galena Biopharma Inc. | SELLAS Life Sciences Group | False Claims Act and related | 2017 | USAO | $7,550,000 |
Ranbaxy USA Inc. | Sun Pharmaceuticals | drug or medical equipment safety violation | 2013 | FDA | $500,000,000 |
Ranbaxy | Sun Pharmaceuticals | drug or medical equipment safety violation | 2013 | MULTI-AG | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $266,729,715 |
Ranbaxy | Sun Pharmaceuticals | False Claims Act and related | 2013 | LA-AG | $5,000,000 |
Ranbaxy Laboratories | Sun Pharmaceuticals | drug or medical equipment safety violation | 2014 | OR-AG | $2,300,000 |
Ranbaxy Pharmaceuticals, Inc. | Sun Pharmaceuticals | price-fixing or anti-competitive practices | 2014 | NY-AG | $150,000 |
Ranbaxy Pharmaceuticals, Inc. et al. | Sun Pharmaceuticals | False Claims Act and related | 2014 | TX-AG | $17,875,000 |
Taro Pharmaceutical Industries | Sun Pharmaceuticals | False Claims Act and related | 2013 | LA-AG | $5,000,000 |
Taro Pharmaceuticals USA, Inc. | Sun Pharmaceuticals | False Claims Act and related | 2014 | TX-AG | $8,750,000 |
DUSA Pharmaceuticals, Inc. | Sun Pharmaceuticals | False Claims Act and related | 2020 | DOJ_CIVIL | $20,750,000 |
MUTUAL PHARMACEUTICAL CO INC | Sun Pharmaceuticals | environmental violation | 2012 | PA-ENV | $8,500 |
Taro Pharmaceuticals USA, Inc. | Sun Pharmaceuticals | False Claims Act and related | 2021 | DOJ_CIVIL | $213,200,000 |
Mutual Pharmaceutical Company, Inc. | Sun Pharmaceuticals | price-fixing or anti-competitive practices | 2014 | private lawsuit-federal | $36,500,000 |
Mutual Pharmaceutical Company, Inc. | Sun Pharmaceuticals | price-fixing or anti-competitive practices | 2015 | private lawsuit-federal | $2,000,000 |
Mutual Pharmaceutical Company, Inc. | Sun Pharmaceuticals | price-fixing or anti-competitive practices | 2015 | private lawsuit-federal | $9,000,000 |
Ranbaxy Laboratories Ltd. | Sun Pharmaceuticals | price-fixing or anti-competitive practices | 2020 | private lawsuit-federal | $3,500,000 |
Ranbaxy, Inc. | Sun Pharmaceuticals | price-fixing or anti-competitive practices | 2022 | private lawsuit-federal | $485,000,000 |
Sun Pharmaceuticals Industries Ltd | Sun Pharmaceuticals | price-fixing or anti-competitive practices | 2019 | private lawsuit-federal | $400,000 |
Sun Pharmaceuticals Industries Ltd | Sun Pharmaceuticals | price-fixing or anti-competitive practices | 2023 | private lawsuit-federal | $17,357,000 |
Taro Pharmaceutical USA Inc. | Sun Pharmaceuticals | price-fixing or anti-competitive practices | 2023 | private lawsuit-federal | $67,643,000 |
SUN PHARMACEUTICAL INDUSTRIES, INC. | Sun Pharmaceuticals | workplace safety or health violation | 2016 | OSHA | $9,620 |
TARO PHARMACEUTICALS USA, INC. | Sun Pharmaceuticals | workplace safety or health violation | 2019 | OSHA | $18,565 |
Shire Pharmaceuticals LLC | Takeda Pharmaceutical | off-label or unapproved promotion of medical products | 2014 | FDA | $56,500,000 |
TAP Pharmaceutical Products Inc. | Takeda Pharmaceutical | False Claims Act and related | 2001 | DOJ_CIVIL | $875,000,000 |
Shire Pharmaceuticals LLC | Takeda Pharmaceutical | False Claims Act and related | 2017 | DOJ_CIVIL | $350,000,000 |
Shire | Takeda Pharmaceutical | False Claims Act and related | 2013 | LA-AG | $4,000,000 |
Shire Pharmaceuticals LLC | Takeda Pharmaceutical | False Claims Act and related | 2017 | MULTI-AG | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $6,104,000 |
Shire Pharmaceuticals LLC | Takeda Pharmaceutical | off-label or unapproved promotion of medical products | 2014 | MULTI-AG | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $20,786,034 |
Takeda Chemical | Takeda Pharmaceutical | price-fixing or anti-competitive practices | 2000 | MULTI-AG | $17,551,650 |
Takeda Chemical | Takeda Pharmaceutical | price-fixing or anti-competitive practices | 2000 | CA-AG | $5,850,550 |
Takeda Chemical | Takeda Pharmaceutical | price-fixing or anti-competitive practices | 2002 | MA-AG | $111,167 |
Takeda Pharmaceuticals | Takeda Pharmaceutical | False Claims Act and related | 2008 | AL-AG | $2,000,000 |
Takeda/Tap Pharmaceuticals | Takeda Pharmaceutical | False Claims Act and related | 2013 | LA-AG | $3,750,000 |
TAP Pharmaceutical Products | Takeda Pharmaceutical | False Claims Act and related | 2011 | PA-AG | $5,240,797 |
TAP Pharmaceutical Products, Inc. | Takeda Pharmaceutical | False Claims Act and related | 2001 | AR-AG | $525,780 |
TAP Pharmaceutical Products, Inc. | Takeda Pharmaceutical | consumer protection violation | 2006 | ID-AG | $198,000 |
TAP Pharmaceutical Products, Inc. | Takeda Pharmaceutical | kickbacks and bribery | 2006 | KY-AG | $600,000 |
TAP Pharmaceutical Products, Inc. | Takeda Pharmaceutical | kickbacks and bribery | 2006 | WI-AG | $798,000 |
TAP Pharmaceutical Products, Inc. | Takeda Pharmaceutical | False Claims Act and related | 2001 | MULTI-AG | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $25,516,440 |
Takeda Pharmaceuticals U.S.A. | Takeda Pharmaceutical | False Claims Act and related | 2019 | IL-AG | $5,833,333 |
Baxalta US Inc. | Takeda Pharmaceutical | wage and hour violation | 2019 | private lawsuit-state | $4,750,000 |
Shire Human Genetic Therapies, Inc. | Takeda Pharmaceutical | environmental violation | 2021 | MA-AG | $600,000 |
Baxalta US, Inc. | Takeda Pharmaceutical | air pollution violation | 2017 | CA-SCAQMD | $35,000 |
Takeda Pharmaceutical Co. Ltd. | Takeda Pharmaceutical | drug or medical equipment safety violation | 2015 | private lawsuit-federal | $2,400,000,000 |
Shire LLC | Takeda Pharmaceutical | price-fixing or anti-competitive practices | 2022 | private lawsuit-federal | $1,850,000 |
Shire US Inc. | Takeda Pharmaceutical | price-fixing or anti-competitive practices | 2016 | private lawsuit-federal | $14,750,000 |
Takeda Chemical | Takeda Pharmaceutical | price-fixing or anti-competitive practices | 2000 | private lawsuit-federal | $22,000,000 |
Takeda Chemical Industries Ltd. | Takeda Pharmaceutical | price-fixing or anti-competitive practices | 2003 | private lawsuit-federal | $22,000,000 |
TAP Pharmaceutical Products | Takeda Pharmaceutical | price-fixing or anti-competitive practices | 2005 | private lawsuit-federal | $150,000,000 |